Tuesday, August 21, 2018
Tags Tecentriq

Tag: Tecentriq

Study Preserves Hopes for Roche’s Tecentriq in Lung Cancer

By John Miller ZURICH (Reuters)  Swiss drugmaker Roche's hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form...

Merck’s Keytruda Extends Lung Cancer Survival in Two Trials

By Deena Beasley CHICAGO (Reuters) Merck & Co's immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with chemotherapy for...

Roche Drugs Show Limited Benefit in Lung, Breast Cancer Trials

By Deena Beasley CHICAGO (Reuters)  In a disappointment for Roche Holding AG, two of its oncology drugs provided only modest protection from disease progression in lung...

Roche, Chasing Merck, Notches Another Lung Cancer Win

By John Miller ZURICH (Reuters) Roche's bid to keep Merck's cancer blockbuster Keytruda within striking distance got a lift on Tuesday when the Swiss drugmaker...

Roche’s Tecentriq Cocktail Adds to Lung Cancer Survival Success

ZURICH (Reuters) Roche's Tecentriq immunotherapy combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss company said as it seeks...

Roche’s Tecentriq Notches Third Cancer Cocktail Trial Win

By John Miller ZURICH (Reuters) Roche's immunotherapy Tecentriq on Tuesday racked up a third trial win in combination with other cancer drugs, a boost for...
banner